Three high-profile moves in weeks means the AI public-market queue is getting crowded, fast.

GSK’s new CEO commits to a major oncology bet: the $10.6bn Nuvalent deal deepens its late-stage pipeline for lung cancer.

At Fortune Brainstorm Tech, Clancy argues real-time connection drives retention, creator value, and AI’s limits.

The filing is real, but OpenAI says key moves are easier as a private company, reshaping timing expectations.

A Primavera surprise set sparks a Rodrigo-Smith collab debut, then turns into a public, mutual praise loop.

The crew returns with an “Mach 39” emblem after a 10-day Moon loop, and NASA explains the measurement fight.

The new policy, tied to Gears of War: E-Day and Clockwork Revolution staying Xbox-only, is Xbox’s bid for a repeatable strategy.

Coinbase CEO Brian Armstrong spells out how routing prompts to cheaper models may cap costs while token usage grows fast.

The side-effect profile of a new monthly GLP-1 rival lands near Novo Nordisk’s weekly target, sharpening the obesity race.

A $20 “Angel Tickets” scheme and $20 ticket pairs kick in later this summer, with half the net going to the Transgender Law Center.

Waves of automated takedowns followed a malicious Azure/durabletask commit that caused instant workflow failure and secret-stealing.

Artists are leaning into homespun imperfections after “script to production is just two weeks” became a PR nightmare.